Olink Proteomics AB is a Swedish AB based in Uppsala, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2016, the company has 394 employees and reported revenue of SEK 1.4bn in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas var för sig av Liminga Björk, Eva Maria Monster, Bram Verhoosel, Michel van der Zande, Petrus Thomas Adrianus
Company purpose
Bolaget skall bedriva utveckling, produktion, marknadsföring och försäljning av bioteknologiska produkter och tjänster och därmed förenlig verksamhet.
In its most recent annual report (2024), Olink Proteomics AB reported revenue of SEK 1.4bn, a decrease of 6% on the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of SEK 479.9m, and the EBITDA margin stood at -38.2%.
At the end of 2024, equity financed 65.7% of the balance sheet, and current assets covered short-term debt 1.3 times.
Frequently asked questions
What is the Org number of Olink Proteomics AB?
Olink Proteomics AB is registered with Bolagsverket / SCB under Org 5590468632.
What is the revenue of Olink Proteomics AB?
Olink Proteomics AB reported revenue of SEK 1.4bn in 2024.
How many employees does Olink Proteomics AB have?
Olink Proteomics AB employs 394 people as of the latest annual report.
Who is the CEO of Olink Proteomics AB?
Eva Maria Liminga Björk is the CEO of Olink Proteomics AB, in role since 2026.
Who is the chairman of Olink Proteomics AB?
Petrus Thomas Adrianus van der Zande chairs the board of Olink Proteomics AB, in role since 2025.
Where is Olink Proteomics AB headquartered?
Olink Proteomics AB's registered address is Salagatan 16 A.
